Prognostic value of low heart rates in patients admitted with acute myocardial infarction.

Acute coronary syndrome Bradicadia Bradycardia Heart rhythm Infarto de miocardio Myocardial infarction Outcomes Resultados Ritmo cardiaco Síndrome coronario agudo

Journal

Revista espanola de cardiologia (English ed.)
ISSN: 1885-5857
Titre abrégé: Rev Esp Cardiol (Engl Ed)
Pays: Spain
ID NLM: 101587954

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 11 10 2022
accepted: 19 01 2023
medline: 31 7 2023
pubmed: 7 2 2023
entrez: 6 2 2023
Statut: ppublish

Résumé

The risk prediction scores adopted in acute coronary syndromes (ACS) use incremental models to estimate mortality for heart rate (HR) above 60 bpm. Nonetheless, previous studies reported a nonlinear relationship between HR and events, suggesting that low HR may have an unrecognized prognostic role. We aimed to assess the prognostic impact of low HR in ACS, defined as admission HR <50 bpm. This study analyzed data from the AMIS Plus registry, a cohort of hospitalized patients with ACS between 1999 and 2021. The primary endpoint was in-hospital all-cause mortality, while a composite of all-cause mortality, major cardiac/cerebrovascular events was set as the secondary endpoint. A multilevel statistical method was used to assess the prognostic role of low HR in ACS. The study included 51 001 patients. Crude estimates showed a bimodal distribution of primary and secondary endpoints with peaks at low and high HR. A nonlinear relationship between HR and in-hospital mortality was observed on restricted cubic spline analysis. An HR of 50 to 75 bpm showed lower mortality than HR <50 bpm (OR, 0.67; 95%CI, 0.47-0.99) only after primary multivariable analysis, which was not confirmed after multiple sensitivity analyses. After propensity score matching, progressive fading of the prognostic role of HR <50 bpm was evident. Low admission HR in ACS is associated with a higher crude rate of adverse events. Nonetheless, after correction for baseline differences, the prognostic role of low HR was not confirmed. Therefore, low HR probably represents a marker of underlying morbidity. These results may be clinically relevant in improving the accuracy of risk scores in ACS.

Identifiants

pubmed: 36746231
pii: S1885-5857(23)00041-5
doi: 10.1016/j.rec.2023.01.008
pii:
doi:

Types de publication

Journal Article

Langues

eng spa

Sous-ensembles de citation

IM

Pagination

626-634

Informations de copyright

Copyright © 2023 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved.

Auteurs

Luigi Biasco (L)

Department of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland. Electronic address: https://twitter.com/@BiascoDr.

Fabienne Foster-Witassek (F)

AMIS Plus Data Center, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.

Dragana Radovanovic (D)

AMIS Plus Data Center, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.

Philip Dittli (P)

Department of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.

Gregorio Tersalvi (G)

Division of Cardiology, Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale, Lugano, Switzerland; Division of Cardiology, Luzerner Kantonsspital, Lucerne, Switzerland. Electronic address: https://twitter.com/@GTersalvi.

Hans Rickli (H)

Division of Cardiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Marco Roffi (M)

Division of Cardiology, University Hospital of Geneva, Geneva, Switzerland.

Franz Eberli (F)

Division of Cardiology, Stadtspital Triemli, Zurich, Switzerland.

Raban Jeger (R)

Division of Cardiology, Stadtspital Triemli, Zurich, Switzerland.

Paul Erne (P)

AMIS Plus Data Center, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.

Giovanni Pedrazzini (G)

Department of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland; Division of Cardiology, Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale, Lugano, Switzerland. Electronic address: giovanni.pedrazzini@eoc.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH